PCI Biotech Holding ASA (OSL:PCIB)

PCI Biotech Holding ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.07	41.18	56.6	116.12	187.97
Cash & Short-Term Investments	27.07	41.18	56.6	116.12	187.97
Cash Growth	-34.27%	-27.23%	-51.26%	-38.22%	-28.01%
Other Receivables	3.84	2.57	6.16	5.1	5.99
Receivables	3.84	2.57	6.16	5.1	5.99
Prepaid Expenses	-	-	-	7.1	7.18
Other Current Assets	-	-0	-	-	-
Total Current Assets	30.91	43.75	62.76	128.32	201.13
Property, Plant & Equipment	0.31	0.3	0.72	7.66	7.99
Other Long-Term Assets	-	-	0	-	0
Total Assets	31.22	44.05	63.48	135.98	209.12
Accounts Payable	1.72	0.71	0.5	3.75	5.19
Accrued Expenses	-	3.94	4.82	15.93	13.98
Current Portion of Leases	0.34	0.32	0.44	0.63	0.67
Other Current Liabilities	5.7	-	-0	0.61	-0
Total Current Liabilities	7.76	4.97	5.75	20.91	19.85
Long-Term Leases	-	-	0.33	1.28	-
Other Long-Term Liabilities	-	0.03	-	-	0.03
Total Liabilities	7.76	5.01	6.08	22.19	19.88
Common Stock	1.12	1.12	111.98	111.98	111.98
Additional Paid-In Capital	-	37.92	-	450.46	450.46
Retained Earnings	-	-	-54.58	-448.65	-373.2
Comprehensive Income & Other	22.33	0	0	-0	-
Shareholders' Equity	23.45	39.04	57.4	113.79	189.24
Total Liabilities & Equity	31.22	44.05	63.48	135.98	209.12
Total Debt	0.34	0.32	0.77	1.91	0.67
Net Cash (Debt)	26.73	40.87	55.83	114.21	187.29
Net Cash Growth	-34.58%	-26.80%	-51.12%	-39.02%	-27.94%
Net Cash Per Share	0.72	1.09	1.50	3.06	5.02
Filing Date Shares Outstanding	37.33	37.33	37.33	37.33	37.33
Total Common Shares Outstanding	37.33	37.33	37.33	37.33	37.33
Working Capital	23.14	38.78	57.01	107.41	181.28
Book Value Per Share	0.63	1.05	1.54	3.05	5.07
Tangible Book Value	23.45	39.04	57.4	113.79	189.24
Tangible Book Value Per Share	0.63	1.05	1.54	3.05	5.07
Machinery	-	-	10	10	9.66

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.